BENZYLAMINOCHINUCLIDINEN MIT EIN DURCH EIN HETERONOM SUBSTITUIERTES ALKYL ALS SUBSTANZ P ANTAGONISTE
PCT No. PCT/JP94/00781 Sec. 371 Date Nov. 20, 1995 Sec. 102(e) Date Nov. 20, 1995 PCT Filed May 13, 1994 PCT Pub. No. WO94/26740 PCT Pub. Date Nov. 24, 1994Compounds useful in the treatment of inflammatory disorders, central nervous system disorders and other disorders of the formula I and the pharm...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | German |
Published |
03.04.2003
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | PCT No. PCT/JP94/00781 Sec. 371 Date Nov. 20, 1995 Sec. 102(e) Date Nov. 20, 1995 PCT Filed May 13, 1994 PCT Pub. No. WO94/26740 PCT Pub. Date Nov. 24, 1994Compounds useful in the treatment of inflammatory disorders, central nervous system disorders and other disorders of the formula I and the pharmaceutically-acceptable salts thereof; (I) wherein R is C1-C6 alkyl; X is C1-C6 alkyl having one or more substituents which include at least one heteroatom; Ar1 and Ar2 are each, independently, aryl optionally substituted by one C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylthio, halogen, cyano, nitro, phenoxy, mono C1-C6 alkylamino, di C1-C6 alkylamino, halosubstituted C1-C6 alkyl, or halosubstituted C1-C6 alkoxy; Y is hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C3-C8 cycloalkyl, Z-(CH2)p-, or W-(CH2)m-CHR2-(CH2)n-NR1CO- wherein Y is at the 4-, 5- or 6-position on the quinuclidine ring; R1 is hydrogen, C1-C6 alkyl, benzyl or -(CH2)r-W; R2 is hydrogen or C1-C6 alkyl which may be substituted by one hydroxy, amino, methylthio, methylmercapto, benzyl, 4-hydroxybenzyl, 3-indolylmethyl or -(CH2)r-W; R1 may form a ring with R2; Z is C1-C6 alkoxy, -CONR4R5, -CO2R4, -CHR4OR5, -CHR4NR5R6, -COR4, -CONR4OR5 or optionally substituted aryl; each W is independently cyano, hydroxymethyl, C2-C6 alkoxymethyl, aminomethyl, mono C1-C6 alkylaminomethyl, di C1-C6 alkylaminomethyl, carboxyl, carbamoyl or C1-C6 alkoxycarbonyl; R4, R5 and R6 are independently hydrogen, C1-C6 alkyl, C1-C6 alkoxy, C3-C8 cycloalkyl or an optionally substituted aryl or heterocyclic group; p is 0 to 6; and m, n and r are each, independently, 0 to 3. |
---|---|
AbstractList | PCT No. PCT/JP94/00781 Sec. 371 Date Nov. 20, 1995 Sec. 102(e) Date Nov. 20, 1995 PCT Filed May 13, 1994 PCT Pub. No. WO94/26740 PCT Pub. Date Nov. 24, 1994Compounds useful in the treatment of inflammatory disorders, central nervous system disorders and other disorders of the formula I and the pharmaceutically-acceptable salts thereof; (I) wherein R is C1-C6 alkyl; X is C1-C6 alkyl having one or more substituents which include at least one heteroatom; Ar1 and Ar2 are each, independently, aryl optionally substituted by one C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylthio, halogen, cyano, nitro, phenoxy, mono C1-C6 alkylamino, di C1-C6 alkylamino, halosubstituted C1-C6 alkyl, or halosubstituted C1-C6 alkoxy; Y is hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C3-C8 cycloalkyl, Z-(CH2)p-, or W-(CH2)m-CHR2-(CH2)n-NR1CO- wherein Y is at the 4-, 5- or 6-position on the quinuclidine ring; R1 is hydrogen, C1-C6 alkyl, benzyl or -(CH2)r-W; R2 is hydrogen or C1-C6 alkyl which may be substituted by one hydroxy, amino, methylthio, methylmercapto, benzyl, 4-hydroxybenzyl, 3-indolylmethyl or -(CH2)r-W; R1 may form a ring with R2; Z is C1-C6 alkoxy, -CONR4R5, -CO2R4, -CHR4OR5, -CHR4NR5R6, -COR4, -CONR4OR5 or optionally substituted aryl; each W is independently cyano, hydroxymethyl, C2-C6 alkoxymethyl, aminomethyl, mono C1-C6 alkylaminomethyl, di C1-C6 alkylaminomethyl, carboxyl, carbamoyl or C1-C6 alkoxycarbonyl; R4, R5 and R6 are independently hydrogen, C1-C6 alkyl, C1-C6 alkoxy, C3-C8 cycloalkyl or an optionally substituted aryl or heterocyclic group; p is 0 to 6; and m, n and r are each, independently, 0 to 3. |
Author | SATAKE, KUNIO |
Author_xml | – fullname: SATAKE, KUNIO |
BookMark | eNqNir0OgjAURjvo4N87NO4OiD9xLOVqbyy3hl4GWAjROhkgwfePRn0Al--c5HxTMWq7NkzELQGqSqsyJKcNUqEtpkhAMkOWgCTTItfmYwYYckcuk75IPCMXCDmDl8qeS_te_w2KKnmRilidHKFnmIvxvXkMYfHjTCyPwNqsQt_VYeiba2jDs05hd9jE0X4bMa_jv04vcpw3tg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 7 |
ExternalDocumentID | DE69431751TT2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_DE69431751TT23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:26:45 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_DE69431751TT23 |
Notes | Application Number: DE19946031751T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030403&DB=EPODOC&CC=DE&NR=69431751T2 |
ParticipantIDs | epo_espacenet_DE69431751TT2 |
PublicationCentury | 2000 |
PublicationDate | 20030403 |
PublicationDateYYYYMMDD | 2003-04-03 |
PublicationDate_xml | – month: 04 year: 2003 text: 20030403 day: 03 |
PublicationDecade | 2000 |
PublicationYear | 2003 |
RelatedCompanies | PFIZER INC., NEW YORK |
RelatedCompanies_xml | – name: PFIZER INC., NEW YORK |
Score | 2.5700445 |
Snippet | PCT No. PCT/JP94/00781 Sec. 371 Date Nov. 20, 1995 Sec. 102(e) Date Nov. 20, 1995 PCT Filed May 13, 1994 PCT Pub. No. WO94/26740 PCT Pub. Date Nov. 24,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | BENZYLAMINOCHINUCLIDINEN MIT EIN DURCH EIN HETERONOM SUBSTITUIERTES ALKYL ALS SUBSTANZ P ANTAGONISTE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030403&DB=EPODOC&locale=&CC=DE&NR=69431751T2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1BT8IwFG4IGvWmqFFR0xizG5GxwdxhMVtbXHV0hHUGuBA2tkQPQGTGv-9bBfTEpWnapGmbvPd9X_tei9C9npfQMrMbVpZlIFAs8IP2VAeVYut5lreBZZS5wz3R8WPzZdgeVtDHJhdGvRP6rR5HBItKwd4L5a-Xf4dYVMVWrh6Sd2haPHWlQ7WNOgZx3jQ06jmsH9KQaIQ4lGli4HRshZS6BHe9BzTaKq2BvXllVsryP6R0j9F-H0abFyeoMstq6JBsfl6roYPe-sIbqmvbW52imcfEeBS4PS5C4nMRk4BTLpjA4H4w4wLTeEB8VfMZsNTyh0IcxV4kuYw5A-IaYTd4HQVQRr8drhjjPnaFdJ9DwSPJztBdl0niN2C6k-3eTCjbrky2jHNUnS_m2QXCrU5qWU3gNvY0MVPQWCkooyQ1zNR6BFjML1F9x0BXO3vr6EiFtJXxK8Y1qhafX9kNQHOR3Ko9_QFpeIru |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT8IwFG6IGvGmqFHxR2PMbkTGgLnDYra2uMroCOsMcCFsbIkegMiM_75vFdATl6Zpk6Zt8t73fe17LUIPelZAy8yqmWmagkAxwQ9aUx1UiqVnadYCllHkDvdE24uar8PWsIQ-Nrkw6p3Qb_U4IlhUAvaeK3-9_DvEoiq2cvUYv0PT4rkjbapt1DGI87qhUddm_YAGRCPEpkwTA7ttKaTUJbjrfaDYZmEN7M0tslKW_yGlc4wO-jDaPD9BpVlaQWWy-Xmtgg576wtvqK5tb3WKZi4T45Hv9LgIiMdFRHxOuWACg_vBjAtMowHxVM1jwFKLHwpxGLmh5DLiDIhriB2_O_KhDH87HDHGfewI6bwEgoeSnaH7DpPEq8F0J9u9mVC2XZlsGOdob76YpxcIN9qJadaB21jTuJmAxkpAGcWJ0UzMJ4DF7BJVdwx0tbP3DpU92fMnPhfdKjpS4W1FLItxjfbyz6_0BmA6j2_V_v4AGruN4Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BENZYLAMINOCHINUCLIDINEN+MIT+EIN+DURCH+EIN+HETERONOM+SUBSTITUIERTES+ALKYL+ALS+SUBSTANZ+P+ANTAGONISTE&rft.inventor=SATAKE%2C+KUNIO&rft.date=2003-04-03&rft.externalDBID=T2&rft.externalDocID=DE69431751TT2 |